Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan 12;388(2):183-185.
doi: 10.1056/NEJMc2214293. Epub 2022 Dec 21.

Neutralization against BA.2.75.2, BQ.1.1, and XBB from mRNA Bivalent Booster

Meredith E Davis-Gardner  1 , Lilin Lai  1 , Bushra Wali  1 , Hady Samaha  1 , Daniel Solis  2 , Matthew Lee  1 , Andrea Porter-Morrison  1 , Ian T Hentenaar  1 , Fumiko Yamamoto  2 , Sucheta Godbole  3 , Yuan Liu  1 , Daniel C Douek  3 , Frances Eun-Hyung Lee  1 , Nadine Rouphael  1 , Alberto Moreno  1 , Benjamin A Pinsky  2 , Mehul S Suthar  4
Affiliations

Neutralization against BA.2.75.2, BQ.1.1, and XBB from mRNA Bivalent Booster

Meredith E Davis-Gardner et al. N Engl J Med. .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1. Neutralizing Responses against the WA1/2020 Strain and Omicron Subvariants.
Shown is the neutralization activity against the WA1/2020 strain of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the omicron subvariants BA.1, BA.5, BA.2.75.2, BQ.1.1, and XBB in 12 participants who received one monovalent booster (Panel A), in 11 participants who received two monovalent boosters (Panel B), and in 12 participants who received the updated bivalent booster (Panel C). The focus reduction neutralization test (FRNT50 [the reciprocal dilution of serum that neutralizes 50% of the input virus]) geometric mean titer (GMT) of neutralizing antibodies against the WA1/2020 strain and each omicron subvariant is shown at the top of each panel, along with the ratio of the neutralization GMT against the WA1/2020 strain to that against each omicron subvariant. The connecting lines between the variants represent matched serum samples. The horizontal dotted lines represent the limit of detection of the assay (FRNT50 GMT 20). The red lines in Panels B and C indicate the participants who reported previous SARS-CoV-2 infection, and the dashed line in Panel C indicates one participant who received two monovalent boosters before the bivalent booster. The colored bars represent the FRNT50 GMT among the participants in the cohort, and the 𝙸 bars indicate 95% confidence intervals, which were not adjusted for multiplicity and may not be used for hypothesis testing. LOD denotes limit of detection, and NA not applicable.
See this image and copyright information in PMC

Update of

References

    1. Edara VV, Manning KE, Ellis M, et al. mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 omicron variant. Cell Rep Med 2022;3:100529-100529. - PMC - PubMed
    1. Lyke KE, Atmar RL, Islas CD, et al. Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant. Cell Rep Med 2022;3:100679-100679. - PMC - PubMed
    1. Chalkias S, Harper C, Vrbicky K, et al. A bivalent omicron-containing booster vaccine against Covid-19. N Engl J Med 2022;387:1279-1291. - PMC - PubMed
    1. Sheward DJ, Kim C, Fischbach J, et al. Omicron sublineage BA.2.75.2 exhibits extensive escape from neutralising antibodies. Lancet Infect Dis 2022;22:1538-1540. - PMC - PubMed
    1. Linderman SL, Lai L, Bocangel Gamarra EL, et al. Neutralizing antibody responses in patients hospitalized with SARS-CoV-2 Delta or Omicron infection. J Clin Invest 2022. October 18 (Epub ahead of print). - PMC - PubMed

Publication types